ONC Q1 2024 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q1 2024 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$752M+67.9% YoY

Gross Profit

$627M83.4% margin

Operating Income

-$261M-34.8% margin

Net Income

-$251M-33.4% margin

EPS (Diluted)

$-2.47

QoQ Revenue Growth

+18.5%

Cash Flow

Operating Cash Flow

-$309M

Free Cash Flow

-$502M

Stock-Based Comp.

$89M

Balance Sheet

Total Assets

$5.7B

Total Liabilities

$2.3B

Stockholders' Equity

$3.4B

Cash & Equivalents

$2.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$752M	$448M	+67.9%
Gross Profit	$627M	$366M	+71.2%
Operating Income	-$261M	-$371M	+29.6%
Net Income	-$251M	-$348M	+27.9%